Intuitive Surgical, Inc. (ISRG) Stock Analysis — Fair Value, Risk & Moat Rating
NMS · Healthcare · Medical Instruments & Supplies
Is Intuitive Surgical, Inc. a safe investment right now?
Intuitive Surgical, Inc.'s Altman Z-Score of 42.85 places it in the safe zone. Our fair value estimate is $328.40 (Overvalued). Moat rating: 3.4/5 stars.
Could Intuitive Surgical, Inc. go bankrupt? Altman Z-Score analysis
Z-Score of 42.85 is above 3.0, indicating the company is financially healthy by this metric.
- Below 1.8 — Distress Zone (high bankruptcy risk)
- 1.8 to 3.0 — Gray Zone (elevated uncertainty)
- Above 3.0 — Safe Zone (financially healthy)
What drives ISRG's Z-Score?
| Component | Formula | Value | Weight | Contribution |
|---|---|---|---|---|
| A · Working Capital / Total Assets | WC / TA | 0.38 | 1.2 | 0.46 |
| B · Retained Earnings / Total Assets | RE / TA | 0.3427 | 1.4 | 0.48 |
| C · EBIT / Total Assets | EBIT / TA | 0.144 | 3.3 | 0.48 |
| D · Market Cap / Total Liabilities | MCap / TL | 68.2428 | 0.6 | 40.95 |
| E · Revenue / Total Assets | Rev / TA | 0.492 | 1.0 | 0.49 |
How has ISRG's financial health changed over time?
| Year | Z-Score | Zone |
|---|---|---|
| 2022 | 57.07 | Safe |
| 2023 | 52.17 | Safe |
| 2024 | 48.27 | Safe |
| 2025 | 42.85 | Safe |
Source: Calculated from ISRG's latest 10-K filing on SEC EDGAR.
What is Intuitive Surgical, Inc. actually worth?
How we calculated this
| Input | Value | Source |
|---|---|---|
| Predicted EPS (α) | $8.21 | Proprietary blend of reported actuals (5Q actual) + analyst consensus, weighted by α |
| Last Year EPS | $6.42 | Annual report (SEC EDGAR) |
| Analyst Consensus EPS (This Year) | $10.00 | 30 analysts consensus |
| Trailing P/E | 58.8x | Current market pricing |
| Fair P/E (β discount) | 40.0x | Trailing PE adjusted by value discount factor β, hard-capped |
| Earnings Trend (γ) | Stable | Directional signal: predicted vs trailing EPS |
Wall Street Reference: Analyst consensus target price is $591.51 (30 analysts). This is shown for reference only and is not used in our valuation model.
Source: Earnings data from SEC EDGAR filings. Market data via Yahoo Finance.
Does Intuitive Surgical, Inc. have a durable competitive advantage?
Moat rating: 3.4/5.
What makes up ISRG's moat score?
ROIC Stability
ROIC variability over the past decade. Score: 4/5.
Gross Margin Trend
Gross margin trajectory over the past decade. Score: 3/5.
Switching Costs
Estimated customer lock-in based on margin level. Score: 3/5.
How stable is ISRG's return on invested capital?
| Year | ROIC | Trend |
|---|---|---|
| 2022 | 14.3% | — |
| 2023 | 13.3% | Stable |
| 2024 | 14.3% | Rising |
| 2025 | 16.5% | Rising |
Source: ROIC calculated from SEC EDGAR filings.
Is Intuitive Surgical, Inc.'s dividend safe?
Intuitive Surgical, Inc.'s key financial metrics
| Metric | Latest | 1Y Ago | 3Y Ago | Trend |
|---|---|---|---|---|
| Revenue | $10.1B | $8.4B | $6.2B | Rising |
| Net Income | $2.9B | $2.3B | $1.3B | Rising |
| Free Cash Flow | $2.5B | $1.3B | $1.0B | Rising |
| Gross Margin | 66.0% | 67.5% | 67.4% | Stable |
Recent events that affect our ISRG analysis
ISRG earnings report scheduled
Upcoming report. Consensus EPS estimate: $2.47. Revenue estimate: $2.79B. Our current Fair Value: $328.40 — a significant beat or miss could shift this estimate.
ISRG analyst consensus: 68% bullish (23 of 34 analysts)
7 Strong Buy, 16 Buy, 9 Hold, 1 Sell, 1 Strong Sell. Consensus target: $591.51 (22.3% upside). Compare with our independent Fair Value: $328.40.
ISRG filed quarterly report (10-Q)
Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →
ISRG beat EPS estimates by 18.7%
Reported EPS: $2.50 vs estimate $2.11. Earnings strength supports our Fair Value of $328.40 (32.1% below current price).
ISRG filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
ISRG filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
ISRG filed annual report (10-K)
Annual filing with full-year financials. Our Altman Z-Score, Moat, and Fair Value models are derived from this data. View on SEC EDGAR →
ISRG beat EPS estimates by 11.6%
Reported EPS: $2.53 vs estimate $2.27. Earnings strength supports our Fair Value of $328.40 (32.1% below current price).
ISRG filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
ISRG filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
ISRG filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
ISRG filed quarterly report (10-Q)
Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →
ISRG beat EPS estimates by 20.7%
Reported EPS: $2.40 vs estimate $1.99. Earnings strength supports our Fair Value of $328.40 (32.1% below current price).
ISRG filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
ISRG filed quarterly report (10-Q)
Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →
ISRG beat EPS estimates by 14.1%
Reported EPS: $2.19 vs estimate $1.92. Earnings strength supports our Fair Value of $328.40 (32.1% below current price).
ISRG filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
ISRG filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
ISRG filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
ISRG filed quarterly report (10-Q)
Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →
ISRG beat EPS estimates by 4.4%
Reported EPS: $1.81 vs estimate $1.73. Earnings strength supports our Fair Value of $328.40 (32.1% below current price).
ISRG filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
ISRG filed annual report (10-K)
Annual filing with full-year financials. Our Altman Z-Score, Moat, and Fair Value models are derived from this data. View on SEC EDGAR →
ISRG beat EPS estimates by 23.7%
Reported EPS: $2.21 vs estimate $1.79. Earnings strength supports our Fair Value of $328.40 (32.1% below current price).
ISRG filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
ISRG filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
ISRG filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
Common questions about Intuitive Surgical, Inc.
What is Intuitive Surgical, Inc. stock price today?
Intuitive Surgical, Inc. (ISRG) stock price is $483.62 as of the latest market close, traded on the NASDAQ exchange.
What does Intuitive Surgical, Inc. do?
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung.
What is Intuitive Surgical, Inc. market cap?
Intuitive Surgical, Inc. has a market capitalization of $171.77B, classifying it as a large-cap stock in the Healthcare sector.
What sector and industry is ISRG in?
Intuitive Surgical, Inc. operates in the Healthcare sector, specifically within the Medical Instruments & Supplies industry. It trades on the NASDAQ under the ticker symbol ISRG.
Is ISRG stock overvalued or undervalued?
Based on our valuation model, Intuitive Surgical, Inc. trades 47.3% above our fair value estimate — potentially overvalued.
- FairValueLabs Fair Value: $328.40
- Current Price: $483.62
- Valuation Zone: Overvalued
What is ISRG stock forecast and analyst target price?
Based on 30 Wall Street analysts, the consensus price target for Intuitive Surgical, Inc. is $591.51, implying upside of 22.3% from the current price.
- Analyst High Target: $750.00
- Analyst Low Target: $378.00
Note: Analyst targets are shown for reference and are not used in our valuation model.
Is Intuitive Surgical, Inc. revenue and earnings growing?
Here are the analyst consensus growth estimates for Intuitive Surgical, Inc.:
- Revenue growth (current year est.): 14.7%
- EPS growth (current year est.): 12.0%
- Revenue growth (next year est.): 13.5%
- EPS growth (next year est.): 14.2%
What are Intuitive Surgical, Inc.'s key financial metrics?
| Metric | Latest | Trend |
|---|---|---|
| Revenue | $10.1B | Rising |
| Net Income | $2.9B | Rising |
| Free Cash Flow | $2.5B | Rising |
| Gross Margin | 66.0% | Stable |
What is ISRG's P/E ratio?
The price-to-earnings ratio measures how much investors pay per dollar of earnings:
- Trailing P/E (last 12 months): 58.8x
- Forward P/E (next 12 months est.): 41.2x
- FairValueLabs Fair P/E: 40.0x
How volatile is ISRG stock?
Intuitive Surgical, Inc. has a beta of 1.68, meaning it is significantly more volatile than the broader market. A beta above 1.0 indicates higher price swings relative to the S&P 500, while below 1.0 suggests more stability.
How much cash and debt does Intuitive Surgical, Inc. have?
Intuitive Surgical, Inc.'s balance sheet shows:
- Total Cash: $7.98B
- Total Debt: N/A
- Net Cash Position: $7.98B
A positive net cash position means the company holds more cash than debt, reducing financial risk.
Does Intuitive Surgical, Inc. pay a dividend?
Intuitive Surgical, Inc. does not currently pay a regular dividend to shareholders. The company may be reinvesting all profits back into growth, or it may have suspended its dividend.
Is Intuitive Surgical, Inc. at risk of going bankrupt?
Intuitive Surgical, Inc.'s Altman Z-Score is 42.85, placing it in the safe zone (above 3.0) — bankruptcy risk is low. The Z-Score uses five balance sheet ratios to predict bankruptcy probability within two years.
Does Intuitive Surgical, Inc. have a durable competitive advantage?
Intuitive Surgical, Inc. scores 3.4/5 stars (Narrow moat) in our moat analysis:
- ROIC Stability: 4/5
- Gross Margin Trend: 3/5
- Switching Costs: 3/5
A score above 3.5 suggests meaningful pricing power and a defensible market position.
What is ISRG's return on equity (ROE)?
Intuitive Surgical, Inc.'s return on equity is 17.2%. ROE measures how efficiently a company generates profits from shareholder equity. An ROE above 15% is generally considered strong, while below 10% may signal inefficiency.
How do I buy ISRG stock?
ISRG shares can be purchased through any brokerage account that provides access to the NASDAQ. Common steps:
- Open an account with a broker (e.g., Fidelity, Schwab, Interactive Brokers)
- Search for ticker symbol ISRG
- Place a market or limit order for your desired number of shares
This is not investment advice. Always do your own research before buying any stock.
Is ISRG a value stock or speculative?
FairValueLabs classifies Intuitive Surgical, Inc. as Value-Speculation. It has some value characteristics but carries elevated risk factors that make it speculative. Extra due diligence is recommended.
Who is the CEO of Intuitive Surgical, Inc.?
The current CEO of Intuitive Surgical, Inc. is Mr. David J. Rosa.
What is ISRG's earnings per share (EPS)?
Earnings per share measures the company's profit allocated to each outstanding share:
- Trailing EPS (last 12 months): $8.22
- Forward EPS (next 12 months est.): $11.73
- Analyst consensus EPS (this year): $10.00
- Analyst consensus EPS (next year): $11.43
Other Healthcare companies analyzed by FairValueLabs
FairValueLabs Disclaimer
All valuations, scores, ratings, and classifications on this page are produced by the FairValueLabs internal valuation system. They do not represent actual market value, guaranteed outcomes, or professional investment advice. These are analytical estimates for educational and research purposes only.
This is not financial advice. All data is sourced from SEC EDGAR public filings. Always consult a qualified financial advisor before making investment decisions.
Last updated: Apr 22, 2026. Data sources: SEC EDGAR (financial statements), Yahoo Finance (market data, analyst consensus). Data may not reflect the most recent quarter.
ISRG analysis methodology: How we calculate fair value, Z-Scores, and moat ratings